In this new era of targeted therapies, the role of clinical trials is more important than ever in providing patients with access to promising new therapies and advancing our knowledge through cutting edge research.
Cancer research has evolved significantly over the last 20 years. Through US Oncology Research, more than 65,000 patients have participated in clinical trials and contributed to the FDA approval of nearly 70 therapies. In this video, physicians share why research is critical to the advancement of cancer care and an important part of their practice.
At Compass Oncology, we sponsor more clinical trials than any other cancer treatment facility in the Portland-Vancouver area. At any given time, we have more than 70 active trials. Continuing to provide our community with access to promising new therapies which may become tomorrow's gold standard remains a top priority at Compass.